Academic Title:
Associate Professor
Primary Appointment:
Pediatrics
Secondary Appointment(s):
Medicine
Email:
Location:
HSF-II, 480
Phone (Primary):
(410) 706-1123
Phone (Secondary):
(410) 706-5328
Fax:
(410) 706-6205
Education and Training
- Columbia College, B.A., Biochemistry, 1998
- University of Pennsylvania School of Medicine, M.D., 2003
- Residency, The Children's Hospital of Philadelphia, Pediatrics, 2003-2006
- Fellowship, University of Maryland School of Medicine, Pediatric Infectious Diseases, 2006-2009
Biosketch
Dr. Berry is a board-certified pediatric infectious disease specialist with an interest in malaria immunology and pediatric vaccine trials. She co-leads the Immunoepidemiology and Pathogenesis Unit within the Malaria Research Program, where she studies the humoral immune response to malaria following natural infection and malaria vaccination. Dr. Berry conducts malaria vaccine trials and challenge studies at the University of Maryland Center for Vaccine Development and Global Health (CVD).
Dr. Berry is a member of the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine and Treatment Evaluation Unit (VTEU) network of investigators. Recent NIAID clinical studies have included trials of pandemic and seasonal influenza vaccines, a study of concurrent use of both licensed brands of rotavirus vaccines within the same schedule, and a study of the immunogenicity of Human Papilloma Virus vaccine when given outside of the recommended schedule.
Dr. Berry also serves as an investigator for several COVID-19 research projects including vaccine trials in adults and pediatrics and the COVID-19 Community Research Partnership.
Research/Clinical Keywords
Malaria, clinical vaccine trials, immunology.
Highlighted Publications
Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population. J Infect Dis. 2020 Sep 29;. doi: 10.1093/infdis/jiaa611. [Epub ahead of print] PubMed PMID: 32992328.
Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. Sci Rep. 2020 Mar 3;10(1):3952. doi: 10.1038/s41598-020-60551-z. PubMed PMID: 32127565; PubMed Central PMCID: PMC7054363.
Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure. mSphere. 2019 Mar 20;4(2). doi: 10.1128/mSphere.00097-19. PubMed PMID: 30894432; PubMed Central PMCID: PMC6429043.
Research Interests
Dr. Berry studies the humoral immune response to malaria following natural infection and malaria vaccination. Her clinical trial experience includes pediatric and adult vaccine studies and controlled human malaria infection.
Clinical Specialty Details
Dr. Berry is a board-certified pediatric infectious disease specialist. She attends on the pediatric infectious disease consult service, where she also teaches medical students, residents, and fellows. In addition, she provides pre-travel consultations at the University of Marlyand School of Medicine Travel Medicine Practice.
Awards and Affiliations
University of Maryland School of Medicine Passano Foundation Clinician-Investigator Award (2016)
Professional Society Memberships:
- American Academy of Pediatrics
- Pediatric Infectious Disease Society
- Infectious Disease Society of America
- American Society of Tropical Medicine and Hygiene
Grants and Contracts
Grants
2/6/2017 – 1/31/2022 (PI)
Protein microarray antibody responses to P. falciparum in a human challenge model
NIH K23 AI125720
2/1/2019 – 1/31/2024 (Co-Investigator) PI: Joana Carneiro Da Silva
Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine
NIH R01 AI141900
Role: Provide expertise in peptide microarray design, sample selection, and data analysis
3/15/2021 - 3/14/2023 (Co-Investigator) PI: D. Serre
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
NIH R21AI159307
Role: Provide expertise in peptide microarray design, sample selection, and data analysis
Contracts
3UM1AI148689-01S2 (Kotloff); 7/13/2020- 11/30/2021; NIH/NIAID
Vaccine Treatment and Evaluation Unit (VTEU): Infectious Diseases Clinical Research Consortium (IDCRC), Moderna Vaccine Trial
Role: Co-Investigator
SC-75D30120C08405 (Kotloff); 07/01/2020 – 06/30/2021; Vysnova Partners, Inc., CDC
Sub-Contract: Applied Research to Address the COVID-19 Emerging Public Health Emergency
Role: Co-Investigator
UM1AI148689 (Kotloff); 12/01/2020 – 11/30/2021; NIH/NIAID
Implementing Vaccine and Treatment Evaluation Unit (VTEU) clinical site protocols; CoVPN 3004 Novavax Supplement
Role: Co-Investigator
Community Service
- Member, Baltimore City Schools Public Health Advisory Committee
- Member, Baltimore County Public Schools Public Health Advisory Committee
Professional Activity
Member, Planning Committee, Global Health Session at St. Judes/PIDS Annual Meeting
Lab Techniques and Equipment
Protein and peptide microarrays